What they do: Questionnaire-based intake, async-only consultations, no live video visits, no required pre-treatment lab work, no specialist assignment
Beginner Dose: For beginners, it is advisable to start at the lower end (2040 mcg/day) to assess tolerance and minimize side effects
Health-conscious individuals concerned about metabolic health, those with family histories of diabetes or cardiovascular disease, and patients experiencing unexplained fatigue, weight changes, or vision problems should consider this screening (Epicentre 2025)
Results vary, but many patients begin noticing weight loss and appetite changes within the first several weeks of treatment
Risk Profile of Combination Use Stacking two incretin-based agents amplifies the most common adverse effects